A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Pediococcus Pentosaceus LP28 on Obesity
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pediococcus Pentosaceus LP28 (Primary)
- Indications Obesity
- Focus Therapeutic Use
Most Recent Events
- 26 Feb 2016 Biomarkers information updated
- 18 Sep 2012 New trial record